CIMA Labs Licenses Fast-Dissolving Fentanyl to Taiho
Business Review Editor
Abstract
CIMA Labs licensed the exclusive rights to its fast-dissolving OraVescent® (fentanyl) formulation of the breakthrough cancer pain treatment to Taiho Pharmaceutical.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.